GMHCA IS NOT DELIVERING THIS TRAINING
Part 1: Identifying Patients Not On Anticoagulation
Thursday 10th June 8 -9pm
An interactive discussion on anticoagulation recommendations for stroke prevention in patients with NVAF
Objectives
How to improve adherence to guideline recommended prescribing of anticoagulation therapy
Guideline recommendations and approaches to identify patients with NVAF who are not receiving anticoagulation for stroke prevention
Part 2: Switching from Warfarin to a NOAC
Thursday 17th June 8 - 9pm
An interactive discussion on the latest recommendations for practical management of anticoagulation in patients with NVAF
Objectives
Case study: following a patient who is switched from warfarin to apixaban
Key changes in the latest 2021 NICE guidance
The use of ORBIT as a bleeding risk score tool
DOACs as first-line treatment for newly diagnosed patients with NVAF
To discuss the option of switching to a DOAC in patients with NVAF who are already taking a VKA and are stable.